# BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

> **NCT00503607** · PHASE3 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 400 (estimated)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** BLI-800
- **DRUG:** Polyethylene glycol 3350 based bowel preparation

## Key facts

- **NCT ID:** NCT00503607
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2007-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503607, "BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00503607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*